| 000 | 01810 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513220615.0 | ||
| 264 | 0 | _c20001207 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0195-668X | ||
| 024 | 7 |
_a10.1053/euhj.1999.2035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRonner, E | |
| 245 | 0 | 0 |
_aSafety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study. _h[electronic resource] |
| 260 |
_bEuropean heart journal _cSep 2000 |
||
| 300 |
_a1530-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEptifibatide |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aPeptides _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aStreptokinase _xtherapeutic use |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _avan Kesteren, H A | |
| 700 | 1 | _aZijnen, P | |
| 700 | 1 | _aAltmann, E | |
| 700 | 1 | _aMolhoek, P G | |
| 700 | 1 | _avan der Wieken, L R | |
| 700 | 1 | _aCuffie-Jackson, C A | |
| 700 | 1 | _aNeuhaus, K L | |
| 700 | 1 | _aSimoons, M L | |
| 773 | 0 |
_tEuropean heart journal _gvol. 21 _gno. 18 _gp. 1530-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/euhj.1999.2035 _zAvailable from publisher's website |
| 999 |
_c10921163 _d10921163 |
||